Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

12.50 +0.62 (+5.22%)
Delayed Quote Updated: 4:00 PM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
AbCellera (ABCL) Q3 2026 Earnings Call Transcript ↗
Phase II data fueled a $200 million raise and plans for Phase III trials. 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
What AbCellera Biologics (ABCL) Said on Its Q3 Earnings Call ↗
AbCellera Biologics (NASDAQ:ABCL) plans to advance its experimental hot flash treatment ABCL635 into late-stage development in 2027 after reporting positive mid-stage results, while shelving further... 
Via MarketBeat
Topics Earnings
News headline image
AbCellera (ABCL) Q2 2026 Earnings Call Transcript ↗
Lead program ABCL635 Phase 2 enrollment complete with data expected in August. 
Via The Motley Fool
Topics Earnings Intellectual Property
AbCellera Biologics (NASDAQ:ABCL) Misses Q2 Estimates, Falls Short on Revenue and EPS ↗
Via Chartmill
AbCellera Biologics Inc (NASDAQ:ABCL) Reports Narrower-Than-Expected Loss on Patent Settlement Windfall ↗
Via Chartmill
Topics Intellectual Property
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
Here are the top movers in Monday's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
AbCellera’s ABCL-635 Cuts Menopause Hot Flashes 83% in Phase II Trial ↗
AbCellera Biologics (NASDAQ:ABCL) reported top-line four-week results from a Phase II trial of ABCL-635, an investigational non-hormonal treatment for moderate to severe vasomotor symptoms, or hot... 
Via MarketBeat
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers AbCellera Biologics (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's after-market session. The company's market cap stands at $1.9 billion. As per the news, the Q2 earnings report... 
Via Benzinga
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
News headline image
AbCellera Biologics Q2 Earnings Call Highlights ↗
AbCellera Biologics (NASDAQ:ABCL) said it expects to report top-line data “very soon” from its Phase I study of ABCL635, an antibody being evaluated for moderate-to-severe vasomotor symptoms, or hot... 
Via MarketBeat
Topics Earnings
News headline image
AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam ↗
AbCellera Biologics (NASDAQ:ABCL) is emphasizing its transition from a partner-based antibody discovery business to a proprietary drug development company, Chief Financial Officer Andrew Booth said... 
Via MarketBeat
News headline image
AbCellera Biologics Q1 Earnings Call Highlights ↗
AbCellera Biologics (NASDAQ:ABCL) said its first quarter of 2026 was marked by progress in its internal drug pipeline, including interim Phase 1 data for its lead program, ABCL635, and continued... 
Via MarketBeat
Topics Earnings
News headline image
AbCellera (ABCL) Q1 2026 Earnings Transcript ↗
AbCellera (ABCL) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
CRA: Here’s the TFSA Contribution Room for 2026 and Why Now Is the Best Time to Use It ↗
The CRA confirmed $7,000 in TFSA room for 2026. Here's why AbCellera Biologics could be one of the smartest growth stocks to put that money to work in right now. 
Via The Motley Fool
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot
As of February 17, 2026, the biotechnology sector is undergoing its most significant structural transformation in decades, a period now widely termed the "Biotechnology Renaissance." Following a... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
AbCellera Biologics Inc (NASDAQ:ABCL) Reports Mixed Q3 2025 Results with Revenue Beat and Wider Loss ↗
AbCellera's Q3 2025 results show revenue beat estimates, but the net loss widened, causing a negative after-hours stock reaction. 
Via Chartmill
News headline image
AI Stocks Extend Selloff, Nasdaq 100 Eyes Worst Week Since April: What's Moving Markets Friday? ↗
Risk-off sentiment dominated Wall Street on Friday, with selling pressure in AI-linked names intensifying and pushing technology stocks toward their worst week since April. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus ↗
U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed. 
Via Benzinga
Topics Stocks
News headline image
AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Why Did AbCellera's Stock Jump Over 7% After Hours? ↗
AbCellera's stock rose 7.72% in after-hours trading following an 18.49% gain during regular trading, with a strong performance expected in Q3 earnings. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Expert Outlook: AbCellera Biologics Through The Eyes Of 4 Analysts ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
AbCellera Biologics (ABCL) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.